Ajooni Biotech Shareholding Pattern
- Market cap
- ₹53.22 crore
- P/E
- 12.3
- P/B
- 0.58
- ROE
- 4.8%
- Dividend yield
- 1.20%
As of 12-AUG-2026, promoters held 30.53% of Ajooni Biotech (+3.64 pp from 30-JUN-2026), the public 69.47%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Ajooni Biotech shareholding pattern — frequently asked questions
What is the promoter holding in Ajooni Biotech?
Promoters held 30.53% of Ajooni Biotech as of 12-AUG-2026, up 3.64 pp from 26.89% in 30-JUN-2026.
Who owns Ajooni Biotech?
As of 12-AUG-2026, Ajooni Biotech's shareholders were promoters (30.53%), the public 69.47%, as filed with the stock exchanges.
Same Data For Peers
- Akums Drugs and Pharmaceuticals Limited shareholding pattern
- Ajanta Pharma Limited shareholding pattern
- Alivus Life Sciences Limited shareholding pattern
- Dr. Agarwal's Health Care Limited shareholding pattern
- Alkem Laboratories Limited shareholding pattern
- Advanced Enzyme Technologies Limited shareholding pattern
Trade Ajooni Biotech With ATS
Track AJOONI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.